Mechanisms of lipase maturation

Clinical Lipidology

Volumn 5, Issue 1, 2010, Pages 117-130

  Doolittle, Mark H ^a,b   Péterfy, Mikls ^b,c  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Chaperone; Endoplasmic reticulum; Endothelial lipase; Glycosylation; Hepatic lipase; Lipase maturation factor 1; Lipoprotein lipase; Protein folding

Indexed keywords

CALNEXIN; CALRETICULIN; ENDOTHELIAL LIPASE; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM; ENZYME BINDING; ENZYME GLYCOSYLATION; ENZYME MECHANISM; ENZYME METABOLISM; ENZYME REGULATION; ENZYME RELEASE; GENE OVEREXPRESSION; HUMAN; HYPERLIPOPROTEINEMIA TYPE 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW;

PROKARYOTA;

EID: 77649147852     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/clp.09.84     Document Type: Review

References (114)

1. McCoy MG, Sun GS, Marchadier D, Maugeais C, Glick JM, Rader DJ: Characterization of the lipolytic activity of endothelial lipase. J. Lipid Res. 43, 921-929 (2002).
2. Wong H, Schotz MC: The lipase gene family. J. Lipid Res. 43, 993-999 (2002).
3. Mead JR, Irvine SA, Ramji DP: Lipoprotein lipase: structure, function, regulation, and role in disease. J. Mol. Med. 80, 753-769 (2002).
4. Merkel M, Eckel RH, Goldberg IJ: Lipoprotein lipase: genetics, lipid uptake, and regulation. J. Lipid Res. 43, 1997-2006 (2002).
5. Stein Y, Stein O: Lipoprotein lipase and atherosclerosis. Atherosclerosis 170, 1-9 (2003).
6. Goldberg IJ, Eckel RH, Abumrad NA: Regulation of fatty acid uptake into tissues: lipoprotein lipase-and CD36-mediated pathways. J. Lipid Res. 50(Suppl.) S86-S90 (2009).
7. Otarod JK, Goldberg IJ: Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk. Curr. Atheroscler. Rep. 6, 335-342 (2004).
8. van Tilbeurgh H, Roussel A, Lalouel JM, Cambillau C: Lipoprotein lipase. Molecular model based on the pancreatic lipase x-ray structure: consequences for heparin binding and catalysis. J. Biol. Chem. 269, 4626-4633 (1994).
9. Wang H, Eckel RH: Lipoprotein lipase: from gene to obesity. Am. J. Physiol. Endocrinol. Metab. 297, E271-E288 (2009).
10. Perret B, Mabile L, Martinez L, Terce F, Barbaras R, Collet X: Hepatic lipase: structure/function relationship, synthesis, and regulation. J. Lipid Res. 43, 1163-1169 (2002).
11. Santamarina-Fojo S, Gonzalez-Navarro H, Freeman L, Wagner E, Nong Z: Hepatic lipase, lipoprotein metabolism, and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 24, 1750-1754 (2004).
12. Cohen JC, Vega GL, Grundy SM: Hepatic lipase: new insights from genetic and metabolic studies. Curr. Opin. Lipidol. 10, 259-267 (1999).
13. Jansen, H, Verhoeven AJ, Sijbrands EJ: Hepatic lipase: a pro-or anti-atherogenic protein? J. Lipid Res. 43, 1352-1362 (2002).
14. Rader DJ, Jaye M: Endothelial lipase: a new member of the triglyceride lipase gene family. Curr. Opin. Lipidol. 11, 141-147 (2000).
15. Broedl UC, Jin W, Rader DJ: Endothelial lipase: a modulator of lipoprotein metabolism upregulated by inflammation. Trends Cardiovasc. Med. 14, 202-206 (2004).
16. Badellino KO, Rader DJ: The role of endothelial lipase in high-density lipoprotein metabolism. Curr. Opin. Cardiol. 19, 392-395 (2004).
17. Wong H, Davis RC, Hill JS, Yang D, Schotz MC: Lipase engineering: a window into structure-function relationships. Methods Enzymol. 284, 171-184 (1997).
18. Derewenda ZS, Cambillau C: Effects of gene mutations in lipoprotein and hepatic lipases as interpreted by a molecular model of the pancreatic triglyceride lipase. J. Biol. Chem. 266, 23112-23119 (1991).
19. Williams KJ: Molecular processes that handle - and mishandle - dietary lipids. J. Clin. Invest. 118, 3247-3259 (2008).
20. Young SG, Davies BS, Fong LG et al.: GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons. Curr. Opin. Lipidol. 18, 389-396 (2007).
21. Hasham SN, Pillarisetti S: Vascular lipases, inflammation and atherosclerosis. Clin. Chim. Acta 372, 179-183 (2006).
22. Pappan KL, Pan Z, Kwon G et al.: Pancreatic b-cell lipoprotein lipase independently regulates islet glucose metabolism and normal insulin secretion. J. Biol. Chem. 280, 9023-9029 (2005).
23. Paradis ME, Badellino KO, Rader DJ et al.: Endothelial lipase is associated with inflammation in humans. J. Lipid Res. 47, 2808-2813 (2006).
24. Paradis ME, Badellino KO, Rader DJ et al.: Visceral adiposity and endothelial lipase. J. Clin. Endocrinol. Metab. 91, 3538-3543 (2006).
25. Pentikainen MO, Oksjoki R, Oorni K, Kovanen PT: Lipoprotein lipase in the arterial wall: linking LDL to the arterial extracellular matrix and much more. Arterioscler. Thromb. Vasc. Biol. 22, 211-217 (2002).
26. Preiss-Landl K, Zimmermann R, Hammerle G, Zechner R: Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism. Curr. Opin. Lipidol. 13, 471-481 (2002).
27. Pulawa LK, Eckel RH: Overexpression of muscle lipoprotein lipase and insulin sensitivity. Curr. Opin. Clin. Nutr. Metab. Care 5, 569-574 (2002).
28. Winkler FK, D'Arcy A, Hunziker W: Structure of human pancreatic lipase. Nature 343, 771-774 (1990).
29. Griffon N, Jin W, Petty TJ et al.: Identification of the active form of endothelial lipase, a homodimer in a head-to-tail conformation. J. Biol. Chem. 284, 23322-23330 (2009).
30. Schrag JD, Cygler M: Lipases and a/b hydrolase fold. Methods Enzymol. 284, 85-107 (1997).
31. Reis P, Holmberg K, Watzke H, Leser ME, Miller R: Lipases at interfaces: a review. Adv. Colloid Interface Sci. 147-148, 237-250 (2009).
32. Lowe ME: The triglyceride lipases of the pancreas. J. Lipid Res. 43, 2007-2016 (2002).
33. Hill JS, Davis RC, Yang D, Schotz MC, Wong H: Hepatic lipase: high-level expression and subunit structure determination. Methods Enzymol. 284, 232-246 (1997).
34. Wong H, Yang D, Hill JS, Davis RC, Nikazy J, Schotz MC: A molecular biology-based approach to resolve the subunit orientation of lipoprotein lipase. Proc. Natl Acad. Sci. USA 94, 5594-5598 (1997).
35. Hide WA, Chan L, Li WH: Structure and evolution of the lipase superfamily. J. Lipid Res. 33, 167-178 (1992).
36. Brunzell JD: Familial lipoprotein lipase deficiency and other causes of chylomicronemia syndromes. In: The Metabolic Basis of Inherited Disease. Scriver RS, Beaudet AL, Sly WS (Eds). McGraw Hill, NY, USA, 1913-1932 (1995).
37. Weinstock PH, Bisgaier CL, Aalto-Setala K et al.: Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J. Clin. Invest. 96, 2555-2568 (1995).
38. Peterfy M, Ben-Zeev O, Mao HZ et al.: Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia. Nat. Genet. 39, 1483-1487 (2007).
39. Beigneux AP, Davies BS, Gin P et al.: Glycosylphosphatidylinositol- anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab. 5, 279-291 (2007).
40. Aulchenko YS, Ripatti S, Lindqvist I et al.: Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat. Genet. 41, 47-55 (2009).
41. Kathiresan S, Willer CJ, Peloso GM et al.: Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56-65 (2009).
42. Sabatti C, Service SK, Hartikainen AL et al.: Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat. Genet. 41, 35-46 (2009).
43. Willer CJ, Sanna S, Jackson AU et al.: Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40, 161-169 (2008).
44. Austin MA, Hokanson JE, Edwards KL: Hypertriglyceridemia as a cardiovascular risk factor. Am. J. Cardiol. 81, B7-B12 (1998).
45. Pejic RN, Lee DT: Hypertriglyceridemia. J. Am. Board Fam. Med. 19, 310-316 (2006).
46. Groop L: Genetics of the metabolic syndrome. Br. J. Nutr. 83(Suppl. 1), S39-S48 (2000).
47. Ginsberg HN, Stalenhoef AF: The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk. J. Cardiovasc. Risk 10, 121-128 (2003).
48. Zechner R, Strauss J, Frank S et al.: The role of lipoprotein lipase in adipose tissue development and metabolism. Int. J. Obes. Relat. Metab. Disord. 24(Suppl. 4), S53-S56 (2000).
49. Levak-Frank S, Radner H, Walsh A et al.: Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J. Clin. Invest. 96, 976-986 (1995).
50. Merkel M, Weinstock PH, Chajek-Shaul T et al.: Lipoprotein lipase expression exclusively in liver. A mouse model for metabolism in the neonatal period and during cachexia. J. Clin. Invest. 102, 893-901 (1998)
51. Ferreira LD, Pulawa LK, Jensen DR, Eckel RH: Overexpressing human lipoprotein lipase in mouse skeletal muscle is associated with insulin resistance. Diabetes 50, 1064-1068 (2001).
52. Kim JK, Fillmore JJ, Chen Y et al.: Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc. Natl Acad. Sci. USA 98, 7522-7527 (2001).
53. Jensen DR, Schlaepfer IR, Morin CL et al.: Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase. Am. J. Physiol. 273, R683-R689 (1997).
54. Goodarzi MO, Guo X, Taylor KD et al.: Lipoprotein lipase is a gene for insulin resistance in Mexican Americans. Diabetes 53, 214-220 (2004).
55. Holzl B, Iglseder B, Sandhofer A et al.: Insulin sensitivity is impaired in heterozygous carriers of lipoprotein lipase deficiency. Diabetologia 45, 378-384 (2002).
56. Jemaa R, Tuzet S, Portos C, Betoulle D, Apfelbaum M, Fumeron F: Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people. Int. J. Obes. Relat. Metab. Disord. 19, 270-274 (1995).
57. Radha V, Vimaleswaran KS, Ayyappa KA, Mohan V: Association of lipoprotein lipase gene polymorphisms with obesity and Type 2 diabetes in an Asian Indian population. Int. J. Obes. (Lond.) 31, 913-918 (2007).
58. Yagyu H, Chen G, Yokoyama M et al.: Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J. Clin. Invest. 111, 419-426 (2003).
59. Park TS, Hu Y, Noh HL et al.: Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J. Lipid Res. 49, 2101-2112 (2008).
60. McGavock JM, Lingvay I, Zib I et al.: Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 116, 1170-1175 (2007).
61. Peterson LR, Herrero P, Schechtman KB et al.: Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109, 2191-2196 (2004).
62. Sharma S, Adrogue JV, Golfman L et al.: Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J. 18, 1692-1700 (2004).
63. Babaev VR, Fazio S, Gleaves LA, Carter KJ, Semenkovich CF, Linton MF: Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J. Clin. Invest. 103, 1697-1705 (1999).
64. Wilson K, Fry GL, Chappell DA, Sigmund CD, Medh JD: Macrophage-specific expression of human lipoprotein lipase accelerates atherosclerosis in transgenic apolipoprotein E knockout mice but not in C57BL/6 mice. Arterioscler. Thromb. Vasc. Biol. 21, 1809-1815 (2001).
65. Izar MC, Helfenstein T, Ihara SS et al.: Association of lipoprotein lipase D9N polymorphism with myocardial infarction in Type 2 diabetes: the genetics, outcomes, and lipids in Type 2 diabetes (GOLD) study. Atherosclerosis 204, 165-170 (2009).
66. Hegele RA, Little JA, Vezina C et al.: Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler. Thromb. 13, 720-728 (1993).
67. Knudsen P, Antikainen M, Uusi-Oukari M et al.: Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL gene. Atherosclerosis 128, 165-174 (1997).
68. Jin W, Millar JS, Broedl U, Glick JM, Rader DJ: Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo. J. Clin. Invest. 111, 357-362 (2003).
69. Broedl UC, Maugeais C, Millar JS et al.: Endothelial lipase promotes the catabolism of ApoB-containing lipoproteins. Circ. Res. 94, 1554-1561 (2004).
70. Edmondson AC, Brown RJ, Kathiresan S et al.: Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans. J. Clin. Invest. 119, 1042-1050 (2009).
71. Hebert DN, Garman SC, Molinari M: The glycan code of the endoplasmic reticulum: asparagine-linked carbohydrates as protein maturation and quality-control tags. Trends Cell Biol. 15, 364-370 (2005).
72. Hebert DN, Molinari M: In and out of the ER: protein folding, quality control, degradation, and related human diseases. Physiol. Rev. 87, 1377-1408 (2007).
73. Trombetta ES, Helenius A: Conformational requirements for glycoprotein reglucosylation in the endoplasmic reticulum. J. Cell Biol. 148, 1123-1129 (2000). (Pubitemid 30688121)
74. Caramelo JJ, Parodi AJ: Getting in and out from calnexin/calreticulin cycles. J. Biol. Chem. 283, 10221-10225 (2008).
75. Ben-Zeev O, Doolittle MH: Maturation of hepatic lipase. Formation of functional enzyme in the endoplasmic reticulum is the rate-limiting step in its secretion. J. Biol. Chem. 279, 6171-6181 (2004).
76. Doolittle MH, Ben-Zeev O, Bassilian S, Whitelegge JP, Peterfy M, Wong H: Hepatic lipase maturation: a partial proteome of interacting factors. J. Lipid Res. 50, 1173-1184 (2009).
77. Ben-Zeev O, Stahnke G, Liu G, Davis RC, Doolittle MH: Lipoprotein lipase and hepatic lipase: the role of asparagine-linked glycosylation in the expression of a functional enzyme. J. Lipid Res. 35, 1511-1523 (1994).
78. Miller GC, Long CJ, Bojilova ED et al.: Role of N-linked glycosylation in the secretion and activity of endothelial lipase. J. Lipid Res. 45, 2080-2087 (2004).
79. Wolle J, Jansen H, Smith LC, Chan L: Functional role of N-linked glycosylation in human hepatic lipase: asparagine-56 is important for both enzyme activity and secretion. J. Lipid Res. 34, 2169-2176 (1993).
80. Zhang L, Lookene A, Wu G, Olivecrona G: Calcium triggers folding of lipoprotein lipase into active dimers. J. Biol. Chem. 280, 42580-42591 (2005).
81. Ben-Zeev O, Doolittle MH, Davis RC, Elovson J, Schotz MC: Maturation of lipoprotein lipase. Expression of full catalytic activity requires glucose trimming but not translocation to the cis-Golgi compartment. J. Biol. Chem. 267, 6219-6227 (1992).
82. Ben-Zeev O, Mao HZ, Doolittle MH: Maturation of lipoprotein lipase in the endoplasmic reticulum. Concurrent formation of functional dimers and inactive aggregates. J. Biol. Chem. 277, 10727-10738 (2002).
83. Briquet-Laugier V, Ben-Zeev O, White A, Doolittle MH: cld and lec23 are disparate mutations that affect maturation of lipoprotein lipase in the endoplasmic reticulum. J. Lipid Res. 40, 2044-2058 (1999).
84. Dejgaard S, Nicolay J, Taheri M, Thomas DY, Bergeron JJ: The ER glycoprotein quality control system. Curr. Issues Mol. Biol. 6, 29-42 (2004).
85. Sitia R, Braakman I: Quality control in the endoplasmic reticulum protein factory. Nature 426, 891-894 (2003).
86. Trombetta ES, Parodi AJ: Quality control and protein folding in the secretory pathway. Annu. Rev. Cell. Dev. Biol. 19, 649-676 (2003).
87. Ruddock LW, Molinari M: N-glycan processing in ER quality control. J. Cell Sci. 119, 4373-4380 (2006).
88. Schroder M, Kaufman RJ: ER stress and the unfolded protein response. Mutat. Res. 569, 29-63 (2005).
89. Meunier L, Usherwood YK, Chung KT, Hendershot LM: A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins. Mol. Biol. Cell 13, 4456-4469 (2002).
90. Boedeker JC, Doolittle MH, White AL: Differential effect of combined lipase deficiency (cld/cld) on human hepatic lipase and lipoprotein lipase secretion. J. Lipid Res. 42, 1858-1864 (2001).
91. Zhang L, Wu G, Tate CG, Lookene A, Olivecrona G: Calreticulin promotes folding/ dimerization of human lipoprotein lipase expressed in insect cells (sf21). J. Biol. Chem. 278, 29344-29351 (2003).
92. Buck TM, Wright CM, Brodsky JL: The activities and function of molecular chaperones in the endoplasmic reticulum. Semin. Cell Dev. Biol. 18, 751-761 (2007).
93. Ni M, Lee AS: ER chaperones in mammalian development and human diseases. FEBS Lett. 581, 3641-3651 (2007).
94. Gething MJ: Role and regulation of the ER chaperone BiP. Semin. Cell Dev. Biol. 10, 465-472 (1999).
95. Blond-Elguindi S, Cwirla SE, Dower WJ et al.: Affinity panning of a library of peptides displayed on bacteriophages reveals the binding specificity of BiP. Cell 75, 717-728 (1993).
96. Paterniti JR Jr, Brown WV, Ginsberg HN, Artzt K: Combined lipase deficiency (cld): a lethal mutation on chromosome 17 of the mouse. Science 221, 167-169 (1983).
97. Reue K, Doolittle MH: Naturally occurring mutations in mice affecting lipid transport and metabolism. J. Lipid Res. 37, 1387-1405 (1996).
98. Davis RC, Ben-Zeev O, Martin D, Doolittle MH: Combined lipase deficiency in the mouse. Evidence of impaired lipase processing and secretion. J. Biol. Chem. 265, 17960-17966 (1990).
99. Scow RO, Schultz CJ, Park JW, Blanchette-Mackie EJ: Combined lipase deficiency (cld/cld) in mice affects differently post-translational processing of lipoprotein lipase, hepatic lipase and pancreatic lipase. Chem. Phys. Lipids 93, 149-155 (1998).
100. Olivecrona T, Chernick SS, Bengtsson-Olivecrona G, Paterniti JR Jr, Brown WV, Scow RO: Combined lipase deficiency (cld/cld) in mice. Demonstration that an inactive form of lipoprotein lipase is synthesized. J. Biol. Chem. 260, 2552-2557 (1985).
101. Blanchette-Mackie EJ, Wetzel MG, Chernick SS, Paterniti JR Jr, Brown WV, Scow RO: Effect of the combined lipase deficiency mutation (cld/cld) on ultrastructure of tissues in mice. Diaphragm, heart, brown adipose tissue, lung, and liver. Lab. Invest. 55, 347-362 (1986).
102. Peterfy M, Mao HZ, Doolittle MH: The cld mutation: narrowing the critical chromosomal region and selecting candidate genes. Mamm. Genome 17, 1013-1024 (2006).
103. Cefalu AB, Noto D, Arpi ML et al.: Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia. J. Clin. Endocrin. Metab. 94, 4584-4590 (2009).
104. Doolittle MH, Neher SB, Ben-Zeev O et al.: Lipase maturation factor 1 (LMF1): Membrane topology and interaction with lipase proteins in the endoplasmic reticulum. J. Biol. Chem. 284, 33623-33633 (2009).
105. Sonnhammer EL, Eddy SR, Durbin R: Pfam: a comprehensive database of protein domain families based on seed alignments. Proteins 28, 405-420 (1997).
106. Molinari M, Eriksson KK, Calanca V et al.: Contrasting functions of calreticulin and calnexin in glycoprotein folding and ER quality control. Mol. Cell 13, 125-135 (2004).
107. Molinari M, Helenius A: Chaperone selection during glycoprotein translocation into the endoplasmic reticulum. Science 288, 331-333 (2000). (Pubitemid 30226193)
108. Lookene A, Zhang L, Hultin M, Olivecrona G: Rapid subunit exchange in dimeric lipoprotein lipase and properties of the inactive monomer. J. Biol. Chem. 279, 49964-49972 (2004).
109. Lookene A, Zhang L, Tougu V, Olivecrona G: 1,1́-bis(anilino)-4-, 4́-bis(naphtalene)-8,8́-disulfonate acts as an inhibitor of lipoprotein lipase and competes for binding with apolipoprotein CII. J. Biol. Chem. 278, 37183-37194 (2003).
110. Osibow K, Frank S, Malli R, Zechner R, Graier WF: Mitochondria maintain maturation and secretion of lipoprotein lipase in the endoplasmic reticulum. Biochem. J. 396, 173-182 (2006).
111. Rozema D, Gellman SH: Artificial chaperone-assisted refolding of denatured-reduced lysozyme: modulation of the competition between renaturation and aggregation. Biochemistry 35, 15760-15771 (1996).
112. Chevet E, Wong HN, Gerber D et al.: Phosphorylation by CK2 and MAPK enhances calnexin association with ribosomes. Embo. J. 18, 3655-3666 (1999).
113. Ritter C, Quirin K, Kowarik M, Helenius A: Minor folding defects trigger local modification of glycoproteins by the ER folding sensor GT. Embo. J. 24, 1730-1738 (2005).
114. Taylor SC, Ferguson AD, Bergeron JJ, Thomas DY: The ER protein folding sensor UDP-glucose glycoprotein glucosyltransferase modifies substrates distant to local changes in glycoprotein conformation. Nat. Struct. Mol. Biol. 11, 128-134 (2004).